Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has submitted the schedule of analyst/institutional investors meeting that the Company would be participating on 27 February 2023. The above information shall be uploaded on the website of the Company at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.